---
schema_version: "secwatch.filing_event.v1"
accession: "0001906324-23-000008"
form_type: "8-K"
ticker: "QDEL"
cik: "0001906324"
company_name: "QuidelOrtho Corp"
filed_at: "2023-02-15T23:59:59+00:00"
generated_at: "2026-06-19T12:15:20.578329+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# QuidelOrtho reports Q4 2022 revenue $866.5M, GAAP EPS $0.45; supplemental adjusted EPS $1.76 down 66% YoY

## Summary
- Q4 GAAP EPS $0.45 vs $6.85 prior year; supplemental adjusted EPS $1.76, down 66% YoY.
- Revenue $866.5M, up 36% as reported; supplemental combined revenue down 23% constant currency ex-COVID.
- Full year 2022 GAAP EPS $9.56; supplemental adjusted EPS $13.80, up 1%.
- Ex-COVID growth driven by Point of Care and Molecular Diagnostics; Labs weak due to China lockdowns and supply chain.
- Integration cost synergies ahead of plan; 2023 guidance to be provided on conference call.

## SEC filing metadata
- accession: 0001906324-23-000008
- form_type: 8-K
- ticker: QDEL
- cik: 0001906324
- company_name: QuidelOrtho Corp
- filed_at: 2023-02-15T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1906324/000190632423000008/0001906324-23-000008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1906324/000190632423000008/qdel-20230215.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001906324-23-000008
- JSON: https://secwatch.observer/filing/0001906324-23-000008.json
- Plain text: https://secwatch.observer/filing/0001906324-23-000008.txt

## Key facts
- Earnings Releases
  QuidelOrtho Corp reported fourth quarter ended January 1, 2023 results: revenue $866.5 million, EPS $0.45.
  - Period: fourth quarter ended January 1, 2023
  - Revenue: $866.5 million
  - EPS: $0.45
  - Result: reported results
  source text: language in such filing. --- EX-99.1 (EX-99.1) --- QuidelOrtho Reports Fourth Quarter and Full Year 2022 Financial Results Highlights • Fourth quarter revenue of $866.5 million increased by 36% as reported and 19% on a supplemental combined basis, excluding COVID-19 revenue • Full year revenue of $3.27 billion increased by 92% as reported; Supplemental
  evidence_url: https://www.sec.gov/Archives/edgar/data/1906324/000190632423000008/0001906324-23-000008-index.htm
- Earnings Releases
  QuidelOrtho Corp reported full year ended January 1, 2023 results: revenue $3.27 billion, EPS $9.56.
  - Period: full year ended January 1, 2023
  - Revenue: $3.27 billion
  - EPS: $9.56
  - Result: reported results
  source text: Full year revenue of $3.27 billion increased by 92% as reported
  evidence_url: https://www.sec.gov/Archives/edgar/data/1906324/000190632423000008/0001906324-23-000008-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.